loading...| Preferred Name |
Moxalactam |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C670 |
| CAS_Registry |
64952-97-2 |
| CHEBI_ID |
CHEBI:599928 |
| Chemical_Formula |
C20H20N6O9S |
| code |
C670 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A semisynthetic oxa-beta-lactam antibiotic, with antibacterial activity used mainly against gram-negative aerobic bacteria. Replacing the beta-lactam sulfur atom for an oxygen atom and the presence of the methyltetrazolethio moiety and the para-hydroxyphenylmalonyl group, increases the antibacterial activity of moxalactam. The 7-alpha-methoxy group and the para-hydroxyphenylmalonyl group increases the stability of this agent against beta-lactamases. The use of this agent has been associated with fatal bleeding events. |
| FDA_UNII_Code |
VUF6C936Z3 |
| FULL_SYN |
Ly 127935 MOXALACTAM Moxalactam Moxam Latamoxef |
| Has_Salt_Form | |
| label |
Moxalactam |
| Legacy Concept Name |
Moxalactam |
| NCI_Drug_Dictionary_ID |
39507 |
| PDQ_Closed_Trial_Search_ID |
39507 |
| PDQ_Open_Trial_Search_ID |
39507 |
| Preferred_Name |
Moxalactam |
| prefixIRI |
Thesaurus:C670 |
| prefLabel |
Moxalactam |
| Semantic_Type |
Pharmacologic Substance Organic Chemical Antibiotic |
| UMLS_CUI |
C0026651 |
| subClassOf |